Marshall Wace
HUMA icon

Marshall Wace’s Humacyte HUMA Stock Holding History

Marshall Wace’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$142K Buy
+181,831
New +$169K ﹤0.01% 2881
2026
Q1 		– Sell
-488,369
Closed -$469K – 3426
2025
Q4 		$469K Sell
488,369
-330,585
-40% -$468K ﹤0.01% 2262
2025
Q3 		$1.42M Sell
818,954
-1,820,240
-69% -$3.57M ﹤0.01% 1779
2025
Q2 		$5.52M Buy
2,639,194
+2,590,394
+5,308% +$4.98M 0.01% 1095
2025
Q1 		$83.4K Sell
48,800
-6,117
-11% -$23K ﹤0.01% 2508
2024
Q4 		$277K Sell
54,917
-529,645
-91% -$2.62M ﹤0.01% 2253
2024
Q3 		$3.18M Buy
584,562
+120,900
+26% +$797K ﹤0.01% 1180
2024
Q2 		$2.23M Buy
463,662
+450,031
+3,302% +$2.34M ﹤0.01% 1312
2024
Q1 		$42.4K Sell
13,631
-143,529
-91% -$483K ﹤0.01% 2354
2023
Q4 		$446K Sell
157,160
-19,047
-11% -$48.9K ﹤0.01% 1754
2023
Q3 		$516K Buy
+176,207
New +$583K ﹤0.01% 1713
2022
Q4 		– Sell
-192,530
Closed -$628K – 3146
2022
Q3 		$628K Buy
192,530
+133,702
+227% +$513K ﹤0.01% 2628
2022
Q2 		$189K Buy
+58,828
New +$327K ﹤0.01% 3181
2021
Q2 		– Sell
-45,590
Closed -$494K – 2826
2021
Q1 		$494K Buy
+45,590
New +$498K ﹤0.01% 1948

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Marshall Wace's HUMA Position: Q2 2026 in Review

Marshall Wace opened a new position in Humacyte (HUMA) in Q2 2026: 181,831 shares worth $142K. The stake represents ﹤0.01% of the portfolio and ranks #2881 among its holdings. This is a return to the name: Marshall Wace previously reported a position in HUMA as recently as Q4 2025.

Marshall Wace first reported a position in HUMA in Q1 2021 and has held it in 14 quarters since. The position peaked at $5.52M in Q2 2025. 162 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Marshall Wace held 181,831 shares of Humacyte worth $142K as of Q2 2026.
  • Humacyte was a new Marshall Wace position in Q2 2026.
  • Humacyte made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2881 holding.
  • Marshall Wace first reported a position in Humacyte in Q1 2021 and has held it in 14 quarters since.
  • Marshall Wace's Humacyte position peaked at $5.52M in Q2 2025.
  • 162 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.